Navigation Links
S&R Communications Group Partners With Ovation Pharmaceuticals to Launch Xenazine* (tetrabenazine)

DURHAM, N.C., Jan. 13 /PRNewswire/ -- S&R Communications Group has entered a strategic partnership with Ovation Pharmaceuticals, Inc., to launch Xenazine* (tetrabenazine), a treatment for chorea associated with Huntington's disease (HD). Xenazine is the first and only FDA-approved treatment specifically developed for any HD-related symptom.

"In recent months, the S&R team worked tirelessly to help Ovation launch Xenazine," said S&R President Paul Dreyer. "Having been involved since 2005 in marketing efforts for Xenazine, we know that it is a major advance for those with HD. We are pleased to help Ovation bring this important product to patients, physicians, and caregivers."

Deerfield, Illinois-based Ovation develops, manufactures, and markets therapies to satisfy the unmet needs of patients with severe illnesses. With products available in more than 85 countries, the company is committed to significantly impacting patients' lives through its focus on the central nervous system, hematology/oncology, and hospital-based therapies.

S&R Communications Group is a full-service healthcare marketing and communications company relentlessly pursuing breakthrough creative strategies and programs for its clients. The agency has received numerous awards and other recognition for its work and has earned the respect of its clients in helping them achieve their most ambitious business goals. For more information, visit the award-winning S&R web site at

*Xenazine is a registered trademark of Cambridge Laboratories (Ireland) Limited

SOURCE S&R Communications Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
2. MedThink Communications Retained by NanoBio Corporation
3. National Patient Safety Foundation Partners with Vocera Communications
4. Vida Health Communications, Inc. to Be Honored as Tibbetts Award Winner
5. N. V. Perricone M.D. Cosmeceuticals Elevates Role of Christina Banas to Executive Director Global Communications
6. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
7. Centre De Sante et de Services Sociaux Haut-Richelieu-Rouville in Quebec Selects Alcatel-Lucent and SSP Telecom to Upgrade its Communications Infrastructure
8. AutoTrader Publishing, and Cox Communications Present $500,000 Grant to the Childrens Hospital of the Kings Daughters
9. AHRQ Report Recommends Use of Existing Call Centers to Expand Communications in Public Health Emergencies
10. Telecommunications Technology Boosts Revenue Generation by Billions and Builds Positive Brand Experience
11. Enova Medical Technologies Names Wayne Ramaker Vice President of Marketing and Communications
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... According to an ... by the University of Toronto and the University of British Columbia suggested that laws ... head injuries. The article explains that part of the reason for the controversial conclusion ...
(Date:11/27/2015)... ... , ... A team of Swiss doctors has released a report on mesothelioma ... posted the findings on the website. Click here to read the details now. ... patients who were treated with chemotherapy followed by EPP surgery. Among the 106 patients ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... Lizzie’s Lice ... The company is offering customers 10% off of their purchase of lice treatment product. ... at full price. According to a company spokesperson. “Finding lice is a sure way ...
(Date:11/27/2015)... ... ... Herpes-only dating community in the world, revealed that over 50% of its members are under ... under the age of 50 – or 67% of the population - are infected with ... infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A simply groundbreaking ... is an interesting show that delves into an array of issues that are presently ... could benefit from open dialogue, this show is changing the subjects consumers focus on, ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Nov. 27, 2015  Lannett Company, Inc. (NYSE: ... completed the acquisition of Kremers Urban Pharmaceuticals Inc. ... global biopharmaceuticals company UCB S.A. (Euronext: UCB). ... has acquired KU from UCB for total consideration ... including a customary working capital adjustment, a deduction ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... --> --> ... find optimal contrast weighting of MRI for patients with ... a research agreement with SyntheticMR in order to use SyMRI ... is possible to generate multiple contrast images from a single ... left, thus making it possible to both fine tune images ...
Breaking Medicine Technology: